News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Conference News ESC 2017 Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days Michael O'Riordan August 31, 2017
Presentation ESC 2017 Guidelines for the Management of Valvular Heart Disease Presenter: Helmut Baumgartner August 29, 2017
Presentation ESC 2017 The Viborg Vascular (VIVA) Randomised Screening Trial Presenter: Jes Lindholt August 29, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017